lepunafusp alfa (JR-171) / JCR Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lepunafusp alfa (JR-171) / JCR Pharma
NCT04453085: An Extension Study of JR-171-101 Study in Patients With MPS I

Active, not recruiting
1/2
14
Japan, US, RoW
JR-171 (lepunafusp alfa)
JCR Pharmaceuticals Co., Ltd.
Mucopolysaccharidosis I
04/25
04/25

Download Options